VanEck Associates’s PHYSICIANS REALTY TRUST DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33,361
Closed -$444K 1451
2023
Q4
$444K Buy
33,361
+5,485
+20% +$65.2K ﹤0.01% 1068
2023
Q3
$340K Buy
27,876
+1,155
+4% +$16K ﹤0.01% 1093
2023
Q2
$374K Buy
26,721
+1,791
+7% +$25.4K ﹤0.01% 1088
2023
Q1
$372K Buy
24,930
+1,292
+5% +$19.5K ﹤0.01% 1061
2022
Q4
$342K Buy
23,638
+10,669
+82% +$155K ﹤0.01% 991
2022
Q3
$195K Sell
12,969
-7,439
-36% -$126K ﹤0.01% 1032
2022
Q2
$356K Buy
20,408
+662
+3% +$11.7K ﹤0.01% 965
2022
Q1
$346K Buy
19,746
+2,586
+15% +$45.4K ﹤0.01% 1008
2021
Q4
$323K Buy
17,160
+7,104
+71% +$131K ﹤0.01% 1019
2021
Q3
$177K Buy
10,056
+1,358
+16% +$25.1K ﹤0.01% 1048
2021
Q2
$161K Buy
8,698
+16
+0.2% +$298 ﹤0.01% 1027
2021
Q1
$153K Buy
8,682
+297
+4% +$5.27K ﹤0.01% 970
2020
Q4
$149K Buy
8,385
+2,090
+33% +$37.4K ﹤0.01% 873
2020
Q3
$113K Buy
6,295
+1,333
+27% +$23.7K ﹤0.01% 874
2020
Q2
$87K Buy
4,962
+2,653
+115% +$43.3K ﹤0.01% 871
2020
Q1
$32K Buy
2,309
+1,202
+109% +$22.1K ﹤0.01% 897
2019
Q4
$21K Buy
+1,107
New +$20.3K ﹤0.01% 916

Other funds holding DOC

VanEck Associates's DOC Position: Q1 2024 in Review

VanEck Associates sold out of PHYSICIANS REALTY TRUST (DOC) in Q1 2024, closing a stake of 33,361 shares — an estimated $444K sold.

VanEck Associates first reported a position in DOC in Q4 2019 and held it in 17 quarters. The position peaked at $444K in Q4 2023. 9 funds tracked by Wall St. Rank hold DOC as of Q1 2024.

  • VanEck Associates reported no remaining PHYSICIANS REALTY TRUST position as of Q1 2024 after selling out during the quarter.
  • VanEck Associates sold 33,361 PHYSICIANS REALTY TRUST shares in Q1 2024, an estimated $444K.
  • VanEck Associates first reported a position in PHYSICIANS REALTY TRUST in Q4 2019 and held it in 17 quarters.
  • VanEck Associates's PHYSICIANS REALTY TRUST position peaked at $444K in Q4 2023.
  • 9 funds tracked by Wall St. Rank held PHYSICIANS REALTY TRUST as of Q1 2024.

Based on VanEck Associates's 13F filing for Q1 2024, filed 30 Apr 2024.